Ian Pavord
www.ndmrb.ox.ac.uk
0000-0002-4288-5973
Oxford University
12 papers found
Refreshing results…
Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease
Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)
Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker‐high and ‐low severe asthma
Perspectives of mild asthma patients on maintenance versus as-needed preventer treatment regimens: a qualitative study
Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)
Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma
Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide
A Proposed Revision of the Stepwise Treatment Algorithm in Asthma
Optimal Asthma Control: Time for a New Target
ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthma
Reply to Boulet and Nair: Inhaled Corticosteroids and Adult Asthma
Inhaled Corticosteroid Therapy in Adult Asthma. Time for a New Therapeutic Dose Terminology
Missing publications? Search for publications with a matching author name.